A report released Thursday by the Pharmaceutical Research and Manufacturers of America, a drug industry trade group, shows that there are 83 new HIV/AIDS-related treatments currently in the development pipeline at U.S. and international drug companies. Among the compounds are 14 HIV vaccines and 33 antiretroviral drugs as well as a number of compounds to treat AIDS-related complications. All of the treatments are in human trials or are awaiting Food and Drug Administration approval. According to the report, titled "New Medicines in Development for AIDS," a total of 74 drugs have been approved to treat HIV disease and AIDS-related complications since 1987.
"We now have a large number of medicines in development to attack HIV in a variety of ways," PhRMA senior vice president John Kelly told Dow Jones Business News. "We've made tremendous progress, but we have more to do."